Shen Fang, Wang Xue-Wei, Ge Fei-Fei, Li Yi-Jing, Cui Cai-Lian
Neuroscience Research Institute, Peking University, 38 Xueyuan Road, Beijing 100191, PR China; Department of Neurobiology, School of Basic Medical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, PR China; Key Laboratory of Neuroscience, The Ministry of Education and the Ministry of Health, 38 Xueyuan Road, Beijing 100191, PR China.
Neuroscience Research Institute, Peking University, 38 Xueyuan Road, Beijing 100191, PR China; Department of Neurobiology, School of Basic Medical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, PR China; Key Laboratory of Neuroscience, The Ministry of Education and the Ministry of Health, 38 Xueyuan Road, Beijing 100191, PR China.
Neuropharmacology. 2016 Mar;102:216-28. doi: 10.1016/j.neuropharm.2015.11.008. Epub 2015 Nov 17.
The nitric oxide (NO)/soluble guanylyl cyclase (sGC)/cGMP-dependent protein kinase (PKG) signaling pathway has been reported to play a key role in memory processing. However, little is known about its role in drug-associated reward memory. Here, we report the following. 1) The NO pathway in the CA1 is critical for the retrieval of morphine-associated reward memory. Specifically, the nNOS, sGC and PKG protein levels in the CA1 were increased after the expression of morphine conditioned place preference (CPP). Intra-CA1 injection of an NOS, sGC or PKG inhibitor prevented morphine CPP expression. 2) The involvement of the NO pathway in morphine CPP requires NR2B-containing NMDA receptors (NR2B-NMDARs). NR2B-NMDAR expression was elevated in the CA1 following morphine CPP expression, and intra-CA1 injection of the NR2B-NMDAR antagonist Ro25-6981 not only blocked morphine CPP expression but also inhibited the up-regulation of nNOS, sGC and PKG. Moreover, the Ro25-6981-induced blockade of morphine CPP was abolished by intra-CA1 injection of a NOS substrate or an sGC activator. 3) The NR2B-NMDAR stimulated the NO pathway by up-regulating the phosphorylation of Akt(Ser473). Morphine CPP expression enhanced the pAkt(Ser473) level, which has been corroborated to regulate nNOS activity, and this effect was reversed by intra-CA1 injection of Ro25-6981. 4) GluR1 acted downstream of the NO pathway. The membrane level of GluR1 in the CA1 was increased after morphine CPP expression, and this effect was prevented by pre-injection of a PKG inhibitor into the CA1. Additionally, co-immunoprecipitation revealed an interaction between PKG and GluR1; this result further indicated a role of PKG in regulating GluR1 trafficking. Collectively, the results of our study demonstrated that the activation of the NR2B-NMDAR/NO/sGC/PKG signaling pathway is necessary for the retrieval of morphine-associated reward memory.
据报道,一氧化氮(NO)/可溶性鸟苷酸环化酶(sGC)/环磷酸鸟苷依赖性蛋白激酶(PKG)信号通路在记忆处理中起关键作用。然而,其在药物相关奖赏记忆中的作用却鲜为人知。在此,我们报告如下内容。1)CA1区的NO通路对吗啡相关奖赏记忆的提取至关重要。具体而言,吗啡条件性位置偏爱(CPP)表达后,CA1区的神经元型一氧化氮合酶(nNOS)、sGC和PKG蛋白水平升高。向CA1区内注射NOS、sGC或PKG抑制剂可阻止吗啡CPP的表达。2)NO通路参与吗啡CPP的形成需要含NR2B的N-甲基-D-天冬氨酸受体(NR2B-NMDARs)。吗啡CPP表达后,CA1区的NR2B-NMDAR表达升高,向CA1区内注射NR2B-NMDAR拮抗剂Ro25-6981不仅可阻断吗啡CPP的表达,还能抑制nNOS、sGC和PKG的上调。此外,向CA1区内注射NOS底物或sGC激活剂可消除Ro25-6981对吗啡CPP的诱导性阻断作用。3)NR2B-NMDAR通过上调Akt(Ser473)的磷酸化来刺激NO通路。吗啡CPP表达增强了pAkt(Ser473)水平,这已被证实可调节nNOS活性,而向CA1区内注射Ro25-6981可逆转这种作用。4)谷氨酸受体1(GluR1)在NO通路的下游起作用。吗啡CPP表达后,CA1区GluR1的膜水平升高,而向CA1区内预先注射PKG抑制剂可阻止这种作用。此外,免疫共沉淀显示PKG与GluR1之间存在相互作用;这一结果进一步表明PKG在调节GluR1转运中起作用。总体而言,我们的研究结果表明,NR2B-NMDAR/NO/sGC/PKG信号通路的激活是吗啡相关奖赏记忆提取所必需的。